Disclaimer: GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider
Further optimization of fermentation strategies may enhance production efficiency and expand the industrial applicability of this system
Reaching your goal weight What happens when you reach your target weight
The published literature here is unusually deep: STEP, SUSTAIN, SURPASS, SURMOUNT, and SELECT phase 3 trial programmes collectively span tens of thousands of subjects across glycaemic, body-weight, hepatic-fat, renal, and cardiovascular endpoints
Results from these rigorous clinical trials will be essential to determine whether GLP-1 medications have a legitimate role in addiction treatment and to identify which patient populations might benefit most
In a press release, Viking Therapeutics announced two phase 3 trials are currently ongoing to assess VK2735